University of Massachusetts Center for Clinical and Translational Science

马萨诸塞大学临床与转化科学中心

基本信息

项目摘要

Contact PD/PI: Luzuriaga, Katherine PROJECT SUMMARY/ABSTRACT – O. OVERALL The UMCCTS was organized in 2006 and NIH-funded in 2010 (renewed 2015), with the vision of improving health and health care delivery by advancing the science of translation, by catalyzing high-quality research across the translational spectrum, and by building and supporting a robust translational workforce. Our overarching goal is to speed the development of new products and approaches to advance patient care and community health. As Massachusetts’ only public university system (UMass) partnered with 2 of the state’s safety net clinical systems (UMass Memorial Health Care, UMMHC; Baystate Health), we share an enduring focus on public engagement and societal benefit. The UMCCTS engages a broad range of stakeholders (communities, patient groups, foundations, industry, NCATS and CTSA hubs) to ensure that the research we support and workforce we train address problems important to the communities we serve. With our partners, we identify important problems and needs, develop and validate enabling platforms, provide resources that facilitate transdisciplinary team science, and educate the next generation of investigators. We use data and analytics to generate knowledge, apply that knowledge to improve performance, then use lessons learned to inform and refine the next improvement cycle. UMCCTS Workforce Development programs ensure the future sustainability of the clinical and translational research (CTR) enterprise. Our 5 Specific Aims correspond to the 5 NCATS strategic goals stated in the NCATS FOA and build on our prior successes: Aim 1: Workforce Development: Build and support a transdisciplinary CTR workforce with the knowledge, skills, and institutional environment to advance high-impact translational research; Aim 2: Collaboration/Engagement: Engage stakeholders throughout the translational process to optimize evidence- based, community-integrated research practices and apply these practices to specific projects that improve individual and population health; Aim 3: Integration Across the Lifespan & Underrepresented or Disadvantaged Populations: Improve insights and practices that ensure that discoveries are translated to all who might benefit; Aim 4: Methods & Processes: Develop, test, and share innovative solutions to critical gaps in the translational research process from discovery to community; Aim 5: Informatics: Develop, demonstrate, and disseminate informatics innovations that accelerate both translational science and translational research operations and that provide the essential evidence base for learning health systems. Abbreviations: CECC - Community Engagement and Collaboration Core; CRPG - Clinical Research Professionals Group; D3Health - Center for Data-Driven Discovery in Health Care; PEPP - Preparing Engineers for Professional Practice; SPRC - Science Participation Research Center; TRAcs - Translational Research Accelerator; UMA - UMass Amherst; UMB - UMass Boston; UMD - UMass Dartmouth; UML - UMass Lowell; UMMHC - UMass Memorial Healthcare; UMMS - UMass Medical School Page 185 Project Summary/Abstract Contact PD/PI: Luzuriaga, Katherine
联系PD/PI: Katherine Luzuriaga

项目成果

期刊论文数量(220)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Multiple Imputation based Clustering Validation (MIV) for Big Longitudinal Trial Data with Missing Values in eHealth.
  • DOI:
    10.1007/s10916-016-0499-0
  • 发表时间:
    2016-06
  • 期刊:
  • 影响因子:
    5.3
  • 作者:
    Zhang Z;Fang H;Wang H
  • 通讯作者:
    Wang H
The Preliminary Efficacy of a Sleep Self-management Intervention Using a Personalized Health Monitoring Device during Pregnancy.
  • DOI:
    10.1080/15402002.2020.1851230
  • 发表时间:
    2021-11
  • 期刊:
  • 影响因子:
    3.1
  • 作者:
    Hsiao WH;Paterno MT;Iradukunda F;Hawkins' M
  • 通讯作者:
    Hawkins' M
Hyperglycemia and risk of ventricular tachycardia among patients hospitalized with acute myocardial infarction.
  • DOI:
    10.1186/s12933-018-0779-8
  • 发表时间:
    2018-10-19
  • 期刊:
  • 影响因子:
    9.3
  • 作者:
    Tran HV;Gore JM;Darling CE;Ash AS;Kiefe CI;Goldberg RJ
  • 通讯作者:
    Goldberg RJ
PAPPA-mediated adipose tissue remodeling mitigates insulin resistance and protects against gestational diabetes in mice and humans.
  • DOI:
    10.1126/scitranslmed.aay4145
  • 发表时间:
    2020-11-25
  • 期刊:
  • 影响因子:
    17.1
  • 作者:
    Rojas-Rodriguez R;Ziegler R;DeSouza T;Majid S;Madore AS;Amir N;Pace VA;Nachreiner D;Alfego D;Mathew J;Leung K;Moore Simas TA;Corvera S
  • 通讯作者:
    Corvera S
New Opportunities and Cautionary Insights about Decentralizing and Deglobalizing Clinical Trials During the Great Lockdown.
  • DOI:
    10.46697/001c.17692
  • 发表时间:
    2020-11-03
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Dunlap D;Santos RS;McManus DD;Buchholz BO;Hafer NS;Picard M
  • 通讯作者:
    Picard M
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Katherine F Luzuriaga其他文献

Katherine F Luzuriaga的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Katherine F Luzuriaga', 18)}}的其他基金

University of Massachusetts Center for Clinical Science and Translational Supplement
马萨诸塞大学临床科学和转化补充中心
  • 批准号:
    10261950
  • 财政年份:
    2020
  • 资助金额:
    $ 514.51万
  • 项目类别:
Measurement and characterization of CNS and immune tissue myeloid HIV-1 reservoirs
CNS 和免疫组织骨髓 HIV-1 储存库的测量和表征
  • 批准号:
    10319583
  • 财政年份:
    2018
  • 资助金额:
    $ 514.51万
  • 项目类别:
Measurement and characterization of CNS and immune tissue myeloid HIV-1 reservoirs
CNS 和免疫组织骨髓 HIV-1 储存库的测量和表征
  • 批准号:
    10078877
  • 财政年份:
    2018
  • 资助金额:
    $ 514.51万
  • 项目类别:
University of Massachusetts Center for Clinical and Translational Science
马萨诸塞大学临床与转化科学中心
  • 批准号:
    9137978
  • 财政年份:
    2015
  • 资助金额:
    $ 514.51万
  • 项目类别:
University of Massachusetts Center for Clinical and Translational Science
马萨诸塞大学临床与转化科学中心
  • 批准号:
    10206292
  • 财政年份:
    2015
  • 资助金额:
    $ 514.51万
  • 项目类别:
University of Massachusetts Center for Clinical and Translational Science
马萨诸塞大学临床与转化科学中心
  • 批准号:
    9086537
  • 财政年份:
    2015
  • 资助金额:
    $ 514.51万
  • 项目类别:
University of Massachusetts Center for Clinical and Translational Science
马萨诸塞大学临床与转化科学中心
  • 批准号:
    10426311
  • 财政年份:
    2015
  • 资助金额:
    $ 514.51万
  • 项目类别:
University of Massachusetts Center for Clinical and Translational Science
马萨诸塞大学临床与转化科学中心
  • 批准号:
    10167243
  • 财政年份:
    2015
  • 资助金额:
    $ 514.51万
  • 项目类别:
University of Massachusetts Center for Clinical and Translational Science
马萨诸塞大学临床与转化科学中心
  • 批准号:
    9029610
  • 财政年份:
    2010
  • 资助金额:
    $ 514.51万
  • 项目类别:
University of Massachusetts Center for Clinical and Translational Science
马萨诸塞大学临床与转化科学中心
  • 批准号:
    8490525
  • 财政年份:
    2010
  • 资助金额:
    $ 514.51万
  • 项目类别:

相似海外基金

EXCESS: The role of excess topography and peak ground acceleration on earthquake-preconditioning of landslides
过量:过量地形和峰值地面加速度对滑坡地震预处理的作用
  • 批准号:
    NE/Y000080/1
  • 财政年份:
    2024
  • 资助金额:
    $ 514.51万
  • 项目类别:
    Research Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
  • 批准号:
    2328975
  • 财政年份:
    2024
  • 资助金额:
    $ 514.51万
  • 项目类别:
    Continuing Grant
SHINE: Origin and Evolution of Compressible Fluctuations in the Solar Wind and Their Role in Solar Wind Heating and Acceleration
SHINE:太阳风可压缩脉动的起源和演化及其在太阳风加热和加速中的作用
  • 批准号:
    2400967
  • 财政年份:
    2024
  • 资助金额:
    $ 514.51万
  • 项目类别:
    Standard Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
  • 批准号:
    2328973
  • 财政年份:
    2024
  • 资助金额:
    $ 514.51万
  • 项目类别:
    Continuing Grant
Market Entry Acceleration of the Murb Wind Turbine into Remote Telecoms Power
默布风力涡轮机加速进入远程电信电力市场
  • 批准号:
    10112700
  • 财政年份:
    2024
  • 资助金额:
    $ 514.51万
  • 项目类别:
    Collaborative R&D
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
  • 批准号:
    2328972
  • 财政年份:
    2024
  • 资助金额:
    $ 514.51万
  • 项目类别:
    Continuing Grant
Collaborative Research: A new understanding of droplet breakup: hydrodynamic instability under complex acceleration
合作研究:对液滴破碎的新认识:复杂加速下的流体动力学不稳定性
  • 批准号:
    2332916
  • 财政年份:
    2024
  • 资助金额:
    $ 514.51万
  • 项目类别:
    Standard Grant
Collaborative Research: A new understanding of droplet breakup: hydrodynamic instability under complex acceleration
合作研究:对液滴破碎的新认识:复杂加速下的流体动力学不稳定性
  • 批准号:
    2332917
  • 财政年份:
    2024
  • 资助金额:
    $ 514.51万
  • 项目类别:
    Standard Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
  • 批准号:
    2328974
  • 财政年份:
    2024
  • 资助金额:
    $ 514.51万
  • 项目类别:
    Continuing Grant
Study of the Particle Acceleration and Transport in PWN through X-ray Spectro-polarimetry and GeV Gamma-ray Observtions
通过 X 射线光谱偏振法和 GeV 伽马射线观测研究 PWN 中的粒子加速和输运
  • 批准号:
    23H01186
  • 财政年份:
    2023
  • 资助金额:
    $ 514.51万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了